2007
DOI: 10.1016/j.rcl.2006.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Imaging Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
37
0
3

Year Published

2008
2008
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(40 citation statements)
references
References 110 publications
0
37
0
3
Order By: Relevance
“…This type of cancer is slower growing, has a generally good prognosis, is often well defined and, clinically, can feel benign. Invasive ductal carcinoma remains the most common pathological type: 54% in our series compared with the 70-80% general incidence rate [17]. No in situ cancers were detected, which most likely reflects the lack of CT resolution for fine microcalcification, as discussed above.…”
Section: Pathology Of Ct-detected Breast Cancersmentioning
confidence: 46%
See 1 more Smart Citation
“…This type of cancer is slower growing, has a generally good prognosis, is often well defined and, clinically, can feel benign. Invasive ductal carcinoma remains the most common pathological type: 54% in our series compared with the 70-80% general incidence rate [17]. No in situ cancers were detected, which most likely reflects the lack of CT resolution for fine microcalcification, as discussed above.…”
Section: Pathology Of Ct-detected Breast Cancersmentioning
confidence: 46%
“…The pathology of the lesions in our series identified a higher percentage of invasive lobular carcinoma (18%) than the general incidence rate of 5-10% of all breast cancer [17]. Lobular carcinoma can be difficult to diagnose, both clinically and on mammography, because it can spread diffusely through the breast and may present only as subtle distortion.…”
Section: Pathology Of Ct-detected Breast Cancersmentioning
confidence: 56%
“…7,8 Thus, even with pressures from healthcare cost containment, the emergence of x-ray tomographic systems [9][10][11] and the relative expense of an exam, the number of breast MR studies is likely to continue to grow in the future because of their exquisite soft-tissue delineation. However, breast MR has a substantial false positive rate-13% to 19% 12,13 -and it is imperfect when used to monitor treatment or follow the breast for recurrence 14,15 due to its reliance on gadolinium as a nonspecific contrast agent. The number of false positives caused by the technique is particularly troubling because of the clinical management burden that is created by the increase in contrast-enhancing foci that need to be evaluated.…”
Section: Introductionmentioning
confidence: 99%
“…MR imaging is able to detect bulky residual disease at the lumpectomy site and residual disease in the same quadrant [multifocal] or a different quadrant (multicentric). MR imaging can be helpful in the determination of whether the patient would best be served with directed re-excision [residual disease at the lumpectomy site or multifocal disease] or whether the patient warrants a mastectomy (multicentric disease) [26].…”
Section: Suspicion Of Cancer Recurrencementioning
confidence: 99%